Royce & Associates LP Haemonetics Corp Transaction History

Royce & Associates LP

  • $10.3 Billion
  • Q4 2024

A detailed history of Royce & Associates LP transactions in Haemonetics Corp stock. As of the latest transaction made, Royce & Associates LP holds 1,153,268 shares of HAE stock, worth $73.2 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
1,153,268
Previous 1,210,546 4.73%
Holding current value
$73.2 Million
Previous $97.3 Million 7.45%
% of portfolio
0.88%
Previous 0.92%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$71.16 - $93.38 $4.08 Million - $5.35 Million
-57,278 Reduced 4.73%
1,153,268 $90 Million
Q3 2024

Nov 06, 2024
BUY
$72.45 - $91.58 $2.24 Million - $2.83 Million
30,868 Added 2.62%
1,210,546 $97.3 Million
Q2 2024

Aug 13, 2024
SELL
$81.24 - $97.37 $7.06 Million - $8.46 Million
-86,936 Reduced 6.86%
1,179,678 $97.6 Million
Q1 2024

May 13, 2024
BUY
$71.24 - $85.35 $21.4 Million - $25.6 Million
300,259 Added 31.07%
1,266,614 $108 Million
Q4 2023

Feb 12, 2024
BUY
$80.59 - $92.61 $1.52 Million - $1.74 Million
18,805 Added 1.98%
966,355 $82.6 Million
Q3 2023

Nov 09, 2023
BUY
$82.56 - $93.49 $3.41 Million - $3.86 Million
41,258 Added 4.55%
947,550 $84.9 Million
Q2 2023

Aug 07, 2023
BUY
$80.84 - $89.45 $5.06 Million - $5.59 Million
62,538 Added 7.41%
906,292 $77.2 Million
Q1 2023

May 04, 2023
BUY
$72.75 - $90.6 $1.33 Million - $1.66 Million
18,292 Added 2.22%
843,754 $69.8 Million
Q4 2022

May 23, 2023
SELL
$73.85 - $86.14 $1.35 Million - $1.58 Million
-18,292 Reduced 2.17%
825,462 $64.9 Million
Q4 2022

Feb 13, 2023
SELL
$73.85 - $86.14 $3.64 Million - $4.25 Million
-49,346 Reduced 5.64%
825,462 $64.9 Million
Q3 2022

Nov 03, 2022
BUY
$63.3 - $78.66 $2.1 Million - $2.61 Million
33,223 Added 3.95%
874,808 $64.8 Million
Q2 2022

Aug 04, 2022
BUY
$49.27 - $66.08 $4.16 Million - $5.57 Million
84,341 Added 11.14%
841,585 $54.9 Million
Q1 2022

May 05, 2022
BUY
$43.77 - $63.22 $2.15 Million - $3.11 Million
49,136 Added 6.94%
757,244 $47.9 Million
Q4 2021

Feb 07, 2022
SELL
$49.55 - $74.59 $13.7 Million - $20.6 Million
-276,250 Reduced 28.06%
708,108 $37.6 Million
Q3 2021

Nov 10, 2021
BUY
$57.6 - $70.59 $22 Million - $27 Million
382,812 Added 63.64%
984,358 $69.5 Million
Q2 2021

Aug 06, 2021
BUY
$51.81 - $118.56 $6.89 Million - $15.8 Million
132,961 Added 28.38%
601,546 $40.1 Million
Q1 2021

May 10, 2021
SELL
$111.01 - $139.48 $14.5 Million - $18.2 Million
-130,171 Reduced 21.74%
468,585 $52 Million
Q4 2020

Feb 08, 2021
BUY
$88.75 - $119.95 $1.34 Million - $1.82 Million
15,148 Added 2.6%
598,756 $71.1 Million
Q3 2020

Nov 12, 2020
BUY
$75.65 - $93.58 $6.84 Million - $8.46 Million
90,415 Added 18.33%
583,608 $50.9 Million
Q2 2020

Aug 07, 2020
BUY
$84.96 - $118.91 $9.91 Million - $13.9 Million
116,588 Added 30.96%
493,193 $44.2 Million
Q1 2020

May 12, 2020
BUY
$74.34 - $121.82 $25.8 Million - $42.2 Million
346,436 Added 1148.32%
376,605 $37.5 Million
Q4 2019

Feb 06, 2020
BUY
$114.37 - $129.46 $3.45 Million - $3.91 Million
30,169 New
30,169 $3.47 Million
Q3 2018

Nov 13, 2018
SELL
$89.96 - $114.58 $1.74 Million - $2.21 Million
-19,300 Closed
0 $0
Q2 2018

Aug 09, 2018
SELL
$71.53 - $95.75 $50,071 - $67,025
-700 Reduced 3.5%
19,300 $1.73 Million
Q1 2018

May 14, 2018
BUY
$60.72 - $74.41 $1.2 Million - $1.47 Million
19,792 Added 9515.38%
20,000 $1.46 Million
Q4 2017

Feb 09, 2018
SELL
$44.96 - $58.99 $1,843 - $2,418
-41 Reduced 16.47%
208 $12,000
Q3 2017

Nov 13, 2017
BUY
$40.38 - $44.87 $10,054 - $11,172
249
249 $11,000

Others Institutions Holding HAE

# of Institutions
349
Shares Held
55.7M
Call Options Held
600K
Put Options Held
474K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.26B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email